We could not find any results for:
Make sure your spelling is correct or try broadening your search.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angio... KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. Show more
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that Jeb Ledell has joined the Company as Chief Operating Officer (COO). Mr. Ledell is an accomplished public company COO with a...
–Continuing to build commercial infrastructure; on track for potential sebetralstat launch in Q2 2025– –Multinational regulatory submissions for sebetralstat position Company to transform...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista’s board of directors granted five newly-hired employees inducement options to purchase...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.17 | -1.90369540873 | 8.93 | 9.1 | 8.03 | 669884 | 8.50171588 | CS |
4 | -1.085 | -11.0208227527 | 9.845 | 10.48 | 8.03 | 407096 | 9.00077077 | CS |
12 | -2.67 | -23.3595800525 | 11.43 | 12.85 | 8.03 | 378114 | 10.14831672 | CS |
26 | -3.01 | -25.5734919286 | 11.77 | 15.5 | 8.03 | 383274 | 11.32607579 | CS |
52 | -2.98 | -25.3833049404 | 11.74 | 16.88 | 8.03 | 477009 | 12.39776324 | CS |
156 | -5.71 | -39.4609536973 | 14.47 | 17.345 | 4.12 | 346836 | 10.6882969 | CS |
260 | -8.71 | -49.8568975386 | 17.47 | 45 | 4.12 | 315785 | 15.71471783 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions